-transparent.png){kind=logo}
A short-term treatment with phorbol 12,13-dibutyrate (PDBu) was found to inhibit totally the epidermal growth factor (EGF)-stimulated phosphoinositide hydrolysis in A431 cells, whereas long-term pretreatment with PDBu, which is known to down regulate protein kinase C, induced a greater accumulation of the EGF-triggered inositol phosphate accumulation, particularly of Ins(1,3,4,5)P4. The increased Ins(1,4,5)P3/Ins(1,3,4,5)P4 formation in the PDBu long-term pretreated cells was coincident with the increased Ca2+ influx stimulated by EGF in the same cells. Since long-term pretreatment with PDBu was found to enhance the EGF signals, an explanation for the synergism between EGF and phorbol esters in the induction of DNA synthesis is provided.
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
October 1990,
Endocrinology,
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
April 1990,
The Journal of clinical investigation,
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
September 1988,
Molecular endocrinology (Baltimore, Md.),
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
November 1994,
Biochemical and biophysical research communications,
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
June 1999,
Molecular and cellular biology,
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
September 1990,
The Biochemical journal,
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
June 2006,
Cancer research,
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
January 2003,
Scandinavian journal of clinical and laboratory investigation,
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
February 1984,
The Journal of biological chemistry,
L M Vicentini, and
R Cervini, and
R Zippel, and
P Mantegazza
November 1997,
Journal of receptor and signal transduction research,
